Tuesday, May 24, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Yale researchers uncover how to control the blood-brain barrier with a molecule

by Medical Finance
in News
Dog brains can detect speech and show different activity patterns to many languages
9
SHARES
101
VIEWS
Share on FacebookShare on Twitter

The brain is composed of billions of neurons-; vulnerable cells that require a protective environment to function properly. This delicate environment is protected by 400 miles of specialized vasculature designed to limit which substances come into contact with the brain. This blood-brain barrier is essential for protecting the organ from toxins and pathogens. But in the context of neurological disease, the barrier “becomes your worst enemy,” says Anne Eichmann, Ph.D., Ensign Professor of Medicine (Cardiology) and professor of cellular and molecular physiology, as it also blocks the passage of therapeutic drugs.

For years, it has been the goal of neuroscientists and vascular biologists alike to find the magic bullet for temporarily opening and resealing the barrier for drug administration. Now, Eichmann’s team has developed an antibody as a tool for opening the blood-brain barrier for a couple of hours at a time, allowing for the delivery of drugs to a diseased brain. The team published its findings in Nature Communications on March 4.

This is the first time we’ve figured out how to control the blood-brain barrier with a molecule.”


Anne Eichmann, Ph.D., senior author of the study

The development and maintenance of the blood-brain barrier are dependent on what is called the Wnt signaling pathway, which regulates a number of crucial cellular processes. Eichmann’s team sought to figure out whether this pathway could be modulated to open the barrier “on-demand.”

When Kevin Boyé, a postdoctoral associate at Yale and first author of the study, joined Eichmann’s lab in 2017, he chose to study a molecule known as Unc5B, an endothelial membrane receptor expressed in the endothelial cells of capillaries. He found that if he knocked out this receptor in mice, they died early in their embryonic development because their vasculature failed to form properly, indicating that it was an important molecule in vascular development. He also discovered that a protein known as Claudin5-; which is important for creating the tight junctions between the endothelial cells of the blood-brain barrier-; was also significantly reduced. This made the team realize that the receptor could be important in maintaining this barrier.

There was previously no known link between Unc5B and the Wnt signaling pathway. Through this new study, the team figured out that the Unc5B receptor controls the pathway, functioning as an upstream regulator.

Boyé then went a step further and took the receptor out in adult mice with an already established blood-brain barrier, and found that the barrier remained open in the absence of the receptor. Next, he wanted to determine which ligands-; which bind to receptors and send signals between or inside cells-;were responsible for the barrier effect. He discovered that one ligand, Netrin-1, also caused a blood-barrier defect when it was removed.

Next, the team developed an antibody that could block Netrin-1 from binding to its receptor. Upon injecting the antibody, the team was able disrupt the Wnt signaling pathway, causing the blood-brain barrier to open temporarily on demand.

“It was quite a fascinating journey, especially the development of our blocking antibodies,” says Boyé. “And to see that we can open the blood-brain barrier in a very time-sensitive fashion to promote drug delivery.”

Because the blood-brain barrier blocks entry to all but a tiny subset of small molecules, neurological conditions such as Alzheimer’s, multiple sclerosis, brain tumors, and depression are exceedingly difficult to treat. Having control over the barrier will be helpful for future drug delivery ventures. The team has not yet identified any potential complications but plans to evaluate the efficacy and potential toxicity of the antibody in later research.

“This paves the way to more interesting basic research around how the body builds such a tight barrier to protect its neurons and how can it be manipulated for drug delivery purposes,” says Eichmann. “And then there’s also potential to use this as a delivery platform for drugs to penetrate into the brain.”

In future studies, the team hopes to understand how to apply its findings to chemotherapy delivery for treating brain tumors. They are also currently working to see if they can apply their antibody to other regions of the central nervous system outside of the brain.

Source:

Journal reference:

Boyé, K., et al. (2022) Endothelial Unc5B controls blood-brain barrier integrity. Nature Communications. doi.org/10.1038/s41467-022-28785-9.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

A critical subset of supporting cells may lie at the origins of rare autoimmune disease

A critical subset of supporting cells may lie at the origins of rare autoimmune disease

by Medical Finance
May 24, 2022
0

Supporting actors sometimes steal the show. In a new study published today in Cell, researchers headed by Prof. Ido Amit...

Study: Growing Health - Why Agriculture is Vital to the Health of People and the Planet. Image Credit: Andrii Yalanskyi/Shutterstock

The role of agriculture in health

by Medical Finance
May 24, 2022
0

Agriculture is a key occupation for human life, health, and well-being. It refers to the science of cultivation, growing crops,...

New research focuses on improving the manufacturing process of lab-grown tissue from cells

Cell Guidance Systems and Manchester BIOGEL collaborate to launch PODS-PeptiGels for 3D cell culture

by Medical Finance
May 24, 2022
0

PODS-PeptiGels combine two stand-out technologies in single customisable cell culture environment Provides researchers with a predictable and controlled system, with...

What are the benefits of Irish Life Sciences’ new 2.2 mL square well ‘V’ bottom plate?

Scientific solutions business splits from global medtech company

by Medical Finance
May 24, 2022
0

Olympus Corporation (“Olympus”) announced the completion of the separation of its Scientific Solutions business to a wholly-owned subsidiary, Evident Corporation...

What are the benefits of Irish Life Sciences’ new 2.2 mL square well ‘V’ bottom plate?

Olympus Scientific Solutions is now EVIDENT!

by Medical Finance
May 24, 2022
0

Olympus Corporation (“Olympus”) announced the completion of the separation of its Scientific Solutions business to a wholly-owned subsidiary, Evident Corporation...

Scientists unravel how blood cells mount the first line of defense against viruses

Key protein could be a novel target for treatment of patients with B cell signaling deficiencies

by Medical Finance
May 24, 2022
0

The rules to the kids' game "red light, green light" are easy to follow: red always means stop, and green...

Next Post
Bacterial biofilms use a developmental patterning mechanism seen in plants and animals

Rising temperatures lead to increased prevalence of Vibrio bacteria in UK waters

Study: Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant. Image Credit: creativeneko/Shutterstock

Effectiveness of prior infection in preventing reinfection with Omicron and other SARS-CoV-2 variants in Qatar

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Anatomical structure of biological animal cell with organelles eranicle 1d73b50575dc4546875a4a2fc7d429a6 620x480
    New insights into how NANOG protein facilitates the activation of human cell pluripotency
  • Protein 620x480
    Novel genetic mapping study traces links between DNA variations and blood proteins
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply